Cardiovascular magnetic resonance imaging in the prospective, population-based, Hamburg City Health cohort study: objectives and design.

Publisher: Elsevier Country of Publication: England NLM ID: 9815616 Publication Model: Electronic Cited Medium: Internet ISSN: 1532-429X (Electronic) Linking ISSN: 10976647 NLM ISO Abbreviation: J Cardiovasc Magn Reson Subsets: MEDLINE

Publication: 2024- : London : Elsevier
Original Publication: New York : M. Dekker, Inc., c1998-

Magnetic Resonance Imaging, Cine* ; Research Design*; Atrial Fibrillation/*diagnostic imaging ; Coronary Artery Disease/*diagnostic imaging ; Heart Failure/*diagnostic imaging; Aged ; Atrial Fibrillation/epidemiology ; Atrial Fibrillation/physiopathology ; Contrast Media/administration & dosage ; Coronary Artery Disease/epidemiology ; Coronary Artery Disease/physiopathology ; Female ; Follow-Up Studies ; Germany/epidemiology ; Heart Failure/epidemiology ; Heart Failure/physiopathology ; Humans ; Incidence ; Male ; Meglumine/administration & dosage ; Middle Aged ; Organometallic Compounds/administration & dosage ; Pilot Projects ; Predictive Value of Tests ; Prognosis ; Prospective Studies ; Reproducibility of Results ; Time Factors ; Workflow

Background: The purpose of this work is to describe the objectives and design of cardiovascular magnetic resonance (CMR) imaging in the single center, prospective, population-based Hamburg City Health study (HCHS). The HCHS aims at improving risk stratification for coronary artery disease (CAD), atrial fibrillation (AF) and heart failure (HF).
Methods: The HCHS will finally include 45,000 inhabitants of the city of Hamburg (Germany) between 45 and 74 years who undergo an extensive cardiovascular evaluation and collection of biomaterials. Risk-scores for CAD, AF and HF are used to create enriched subpopulations who are invited for CMR. A total number of approximately 12,362 subjects will undergo CMR and incident CAD, AF and HF will be assessed after 6 years follow-up. The standard CMR protocol includes cine-CMR, T1 and T2 mapping, aortic/mitral valve flow measurements, Late gadolinium enhancement, angiographies and measurements of aortic distensibility. A stress-perfusion scan is added in individuals at risk for CAD. The workflow of CMR data acquisition and analyses was evaluated in a pilot cohort of 200 unselected subjects.
Results: The obtained CMR findings in the pilot cohort agree with current reference values and demonstrate the ability of the established workflow to accomplish the objectives of HCHS.
Conclusions: CMR in HCHS promises novel insights into major cardiovascular diseases, their subclinical precursors and the prognostic value of novel imaging biomarkers. The HCHS database will facilitate combined analyses of imaging, clinical and molecular data ("Radiomics").

J Cardiovasc Magn Reson. 2013 May 01;15:35. (PMID: 23634753)
Circulation. 2000 Mar 28;101(12):1379-83. (PMID: 10736280)
Circ Cardiovasc Imaging. 2012 Nov;5(6):726-33. (PMID: 23071146)
Circulation. 2012 Sep 4;126(10):1206-16. (PMID: 22851543)
Circ Heart Fail. 2012 Jul 1;5(4):422-9. (PMID: 22589298)
Circ Cardiovasc Imaging. 2013 Jul;6(4):590-6. (PMID: 23861451)
JAMA. 2004 Sep 22;292(12):1462-8. (PMID: 15383517)
Radiology. 2007 May;243(2):377-85. (PMID: 17456867)
Eur Heart J. 2012 May;33(10):1268-78. (PMID: 22279111)
J Cardiovasc Magn Reson. 2010 May 11;12:26. (PMID: 20459799)
Circulation. 2005 Dec 13;112(24):3738-44. (PMID: 16330684)
Eur Heart J. 2006 Nov;27(21):2588-605. (PMID: 17000623)
JAMA. 2012 Sep 5;308(9):890-6. (PMID: 22948699)
J Cardiovasc Magn Reson. 2017 Oct 9;19(1):75. (PMID: 28992817)
Magn Reson Med. 2011 Apr;65(4):986-93. (PMID: 21413062)
J Am Coll Cardiol. 2010 Jun 8;55(23):2614-62. (PMID: 20513610)
Circulation. 2011 Dec 6;124(23):2491-501. (PMID: 22064591)
BMC Public Health. 2016 Jul 27;16:650. (PMID: 27464510)
Mayo Clin Proc. 2001 May;76(5):467-75. (PMID: 11357793)
Am Heart J. 2004 Feb;147(2):218-23. (PMID: 14760316)
J Cardiovasc Magn Reson. 2000;2(4):271-8. (PMID: 11545126)
Lancet. 2003 Feb 1;361(9355):374-9. (PMID: 12573373)
Radiology. 2015 Oct;277(1):206-20. (PMID: 25989618)
J Cardiovasc Magn Reson. 2013 Jun 18;15:53. (PMID: 23777327)
J Am Coll Cardiol. 2003 Oct 15;42(8):1446-53. (PMID: 14563590)
J Am Coll Cardiol. 2000 Nov 1;36(5):1557-64. (PMID: 11079658)
Eur Heart J. 2016 Aug 1;37(29):2315-2381. (PMID: 27222591)
Lancet. 2012 Feb 4;379(9814):453-60. (PMID: 22196944)
Radiology. 2008 Dec;249(3):792-800. (PMID: 18849503)
J Cardiovasc Magn Reson. 2015 Apr 18;17:29. (PMID: 25928314)
JACC Cardiovasc Imaging. 2012 Aug;5(8):769-77. (PMID: 22897989)
Eur Heart J. 2003 Jun;24(11):987-1003. (PMID: 12788299)
JACC Cardiovasc Imaging. 2016 Nov;9(11):1338-1348. (PMID: 27832901)
J Am Coll Cardiol. 2010 Dec 14;56(25):e50-103. (PMID: 21144964)
Lancet Neurol. 2017 Jul;16(7):564-570. (PMID: 28653648)
Eur Heart J Cardiovasc Imaging. 2012 Mar;13(3):243-50. (PMID: 22120846)
Eur Heart J. 2013 Mar;34(10):775-81. (PMID: 22390914)
J Am Heart Assoc. 2015 Apr 27;4(4):. (PMID: 25917441)
J Cardiovasc Magn Reson. 2013 May 28;15:46. (PMID: 23714095)
J Am Heart Assoc. 2013 Mar 18;2(2):e000102. (PMID: 23537808)
Eur Heart J. 2014 Oct 1;35(37):2541-619. (PMID: 25173339)
J Cardiovasc Magn Reson. 2014 Nov 20;16:92. (PMID: 25410203)
Eur Heart J. 2013 Oct;34(38):2949-3003. (PMID: 23996286)
J Cardiovasc Magn Reson. 2008 Jul 07;10:35. (PMID: 18605997)
JAMA. 2015 Nov 10;314(18):1945-54. (PMID: 26547466)
Circulation. 2007 Apr 3;115(13):1769-76. (PMID: 17353441)
Circulation. 2002 Jan 29;105(4):539-42. (PMID: 11815441)
JAMA. 2013 Mar 6;309(9):896-908. (PMID: 23462786)
J Am Coll Cardiol. 2012 Jan 31;59(5):435-41. (PMID: 22281245)

Keywords: Atrial fibrillation; CMR; Cardiovascular magnetic resonance; Coronary artery disease; Heart failure; Population-based study; T1 mapping; T2 mapping

0 (Contrast Media)
0 (Organometallic Compounds)
6HG8UB2MUY (Meglumine)
L0ND3981AG (gadoterate meglumine)

Date Created: 20180925 Date Completed: 20190314 Latest Revision: 20240331

20240331

PMC6151919

10.1186/s12968-018-0490-7

30244673